Annual Shareholders Equity
$38.14 M
-$21.96 M-36.54%
31 December 2023
Summary:
INmune Bio annual stockholders equity is currently $38.14 million, with the most recent change of -$21.96 million (-36.54%) on 31 December 2023. During the last 3 years, it has fallen by -$615.00 thousand (-1.59%). INMB annual shareholders equity is now -52.46% below its all-time high of $80.22 million, reached on 31 December 2021.INMB Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$38.67 M
+$1.59 M+4.30%
30 September 2024
Summary:
INmune Bio quarterly stockholders equity is currently $38.67 million, with the most recent change of +$1.59 million (+4.30%) on 30 September 2024. Over the past year, it has dropped by -$6.06 million (-13.54%). INMB quarterly shareholders equity is now -56.18% below its all-time high of $88.25 million, reached on 30 September 2021.INMB Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
INMB Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -36.5% | -13.5% |
| 3 y3 years | -1.6% | -56.2% |
| 5 y5 years | +130.6% | +56.5% |
INMB Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -52.5% | at low | -56.2% | +33.3% |
| 5 y | 5 years | -52.5% | +130.6% | -56.2% | +78.3% |
| alltime | all time | -52.5% | >+9999.0% | -56.2% | +133.8% |
INmune Bio Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $38.67 M(+4.3%) |
| June 2024 | - | $37.08 M(+27.8%) |
| Mar 2024 | - | $29.02 M(-23.9%) |
| Dec 2023 | $38.14 M(-36.5%) | $38.14 M(-14.7%) |
| Sept 2023 | - | $44.73 M(-11.7%) |
| June 2023 | - | $50.65 M(-8.4%) |
| Mar 2023 | - | $55.30 M(-8.0%) |
| Dec 2022 | $60.10 M(-25.1%) | $60.10 M(-5.7%) |
| Sept 2022 | - | $63.71 M(-8.9%) |
| June 2022 | - | $69.93 M(-7.5%) |
| Mar 2022 | - | $75.64 M(-5.7%) |
| Dec 2021 | $80.22 M | $80.22 M(-9.1%) |
| Sept 2021 | - | $88.25 M(+104.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2021 | - | $43.23 M(-32.0%) |
| Mar 2021 | - | $63.56 M(+64.0%) |
| Dec 2020 | $38.75 M(+64.1%) | $38.75 M(-6.0%) |
| Sept 2020 | - | $41.21 M(+90.0%) |
| June 2020 | - | $21.68 M(-3.2%) |
| Mar 2020 | - | $22.41 M(-5.1%) |
| Dec 2019 | $23.61 M(+42.7%) | $23.61 M(-4.4%) |
| Sept 2019 | - | $24.71 M(-7.9%) |
| June 2019 | - | $26.84 M(+17.4%) |
| Mar 2019 | - | $22.86 M(+38.2%) |
| Dec 2018 | $16.54 M(-8.6%) | $16.54 M(-5.3%) |
| Sept 2018 | - | $17.47 M(-3.5%) |
| Dec 2017 | $18.10 M(<-9900.0%) | $18.10 M |
| Dec 2016 | -$149.20 K | - |
FAQ
- What is INmune Bio annual stockholders equity?
- What is the all time high annual shareholders equity for INmune Bio?
- What is INmune Bio annual shareholders equity year-on-year change?
- What is INmune Bio quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for INmune Bio?
- What is INmune Bio quarterly shareholders equity year-on-year change?
What is INmune Bio annual stockholders equity?
The current annual shareholders equity of INMB is $38.14 M
What is the all time high annual shareholders equity for INmune Bio?
INmune Bio all-time high annual stockholders equity is $80.22 M
What is INmune Bio annual shareholders equity year-on-year change?
Over the past year, INMB annual stockholders equity has changed by -$21.96 M (-36.54%)
What is INmune Bio quarterly stockholders equity?
The current quarterly shareholders equity of INMB is $38.67 M
What is the all time high quarterly shareholders equity for INmune Bio?
INmune Bio all-time high quarterly stockholders equity is $88.25 M
What is INmune Bio quarterly shareholders equity year-on-year change?
Over the past year, INMB quarterly stockholders equity has changed by -$6.06 M (-13.54%)